Clinipace Worldwide, a Morrisville-based digital contract research and life sciences services company, has raised more than $3.73 million of a $4.25 million equity offering, according to a regulatory filing.

The company raised about $50 million since 2003 and made six acquisitions in recent years, the most recent Germany-based Accovin, a European CRO.

The company has more than 1,000 employees in 39 countries.

In 2015, Jeff Williams, CEO and co-founder, and Chris Porter, president and co-founder, have been named one of three finalists in the Health Care & Life Sciences category of the Ernst & Young Entrepreneur Of The Year.They founded the company in 2003 as a software firm. From 2012 to 2014, the company experienced a growth rate of 348 percent.

According to the company web site, the Clinipace software program, TEMPO, integrates the spectrum of clinical trial functions, including site selection/management, patient enrollment, project management, monitoring, data management, and biostatistics. The platform is updated in real-time, providing project- and stakeholder-wide visibility of clinical research processes, trial data, and document metadata.

The company disclosed the equity raise in a filing with the U.S. Securities and Exchange Commission Thursday.: